1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. Massachusetts >
  7. Vertex Pharmaceuticals >
  8. M&A

Vertex Pharmaceuticals Mergers & Acquisitions

Vertex Pharmaceuticals M&A Summary

Vertex Pharmaceuticals has acquired 8 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Vertex Pharmaceuticals’ largest acquisition to date was in 2024, when it acquired Alpine Immune Sciences for $4.9B. It’s largest disclosed sale occurred in 2013, when it sold INCIVO to Janssen Pharmaceuticals for $152M. Vertex Pharmaceuticals has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity10
    • M&A Buy Activity8
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 4

Vertex Pharmaceuticals

Vertex Pharmaceuticals, Inc.

50 Northern Avenue,
Boston, Massachusetts 02210
United States,
(617) 341-6100
www.vrtx.com

All (10) Buy (8) Sell (2)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2024-04-10 Alpine Immune Sciences · Life Science
Seattle, Washington · www.alpineimmunesciences.com

Alpine Immune Sciences is focused on developing novel protein-based immunotherapies using its proprietary variant immunoglobulin domain (vIgD™) platform technology. The vIgD platform is designed to interact with multiple targets, including many present in the immune synapse. Alpine’s vIgDs are developed using a unique process known as directed evolution, which can produce proteins capable of either enhancing or diminishing an immune response and thereby may apply therapeutically to both oncology and inflammatory diseases. Alpine Immune Sciences was founded in 2007 and is based in Seattle, Washington.

Revenue (mlns) 59 USD
Advisors: Centerview Partners , Fenwick & West 		4,900
83.1x REVENUE 		Add-on Acquisition

Vertex Pharmaceuticals
Advisors: Lazard , Skadden, Arps, Slate, Meagher & Flom

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal